Skip to main content

Advertisement

Log in

Ambulatory care pharmacy practice in China: status and future efforts

  • Commentary
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

In recent years, as the era of deepening healthcare reform in China progresses, there is a gradual development of ambulatory care pharmacy practice. This commentary reviews the current state of ambulatory care pharmacy practice in China and discusses future efforts to advance the practice. Areas of focus include practice standardization, transitions of care, and reimbursements of ambulatory care pharmacy practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. YI Z, Sun S, LI X, Lu M, Zhai S. An evaluation of clinical pharmacist service on a neurology care unit. Int J Clin Pharm. 2016;38(1):30–3.

    Article  PubMed  Google Scholar 

  2. Wang Z, Mao Z, Li T, Du W. Policy effectiveness analysis of pilot reform in centralized drug purchasing: case study of Sanming City, Fujian Province. Chin J Health Policy. 2017;8(1):21–6.

    Google Scholar 

  3. Yang J, Meng L, Liu Y, Lv L, Sun S, Long R, et al. Drug-related problems among community-dwelling older adults in mainland China. Int J Clin Pharm. 2018;40(2):368–75.

    Article  PubMed  Google Scholar 

  4. National Health Commission of the People’s Republic of China. Notice on Strengthening the Pharmaceutical Administration and Changing the Mode of Pharmaceutical Services. https://www.nhc.gov.cn/. Accessed 5 January 2019.

  5. Zhang J, Liu M, Chen Q, Wu J, Cao H. Outcomes of an online pharmacist-managed anticoagulation clinic for individuals on warfarin therapy living in rural communities. Thromb Res. 2017;157:136–8.

    Article  CAS  PubMed  Google Scholar 

  6. Li X, Sun S, Wang Q, Chen B, Zhao Z, Xu X. Assessment of patients’ warfarin knowledge and anticoagulation control at a joint physician- and pharmacist-managed clinic in China. Patient Prefer Adher. 2018;12:783–91.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Sachdev GP. Ambulatory care pharmacist services: the value proposition. Am J Health Syst Pharm. 2018; 75(21):1688–9.

    Article  Google Scholar 

  8. Buxton JA, Babbitt R, Clegg CA, Durley SF, Epplen KT, Marsden LM, et al. ASHP guidelines: minimum standard for ambulatory care pharmacy practice. Am J Health Syst Pharm. 2016;72(14):1221–366.

    Article  Google Scholar 

  9. Guangdong Pharmaceutical Association. The trial standards of ambulatory care pharmacy practice. Pharmacy Today. 2018;11:721–6.

    Google Scholar 

  10. The Joint Commission. Transitions of Care: the need for a more effective approach to continuing patient care. https://www.jointcommission.org/-/media/deprecated-unorganized/imported-assets/tjc/system-folders/topics-library/hot_topics_transitions_of_carepdf.pdf?db=web&hash=CEFB254D5EC36E4FFE30ABB20A5550E0. Accessed 4 January 2020.

  11. Koehler BE, Richter KM, Youngblood L, Cohen BA, Prengler ID, Cheng D, et al. Reduction of 30-day postdischarge hospital readmission or emergency department (ED) visit rates in high-risk elderly medical patients through delivery of a targeted care bundle. J Hosp Med. 2009;4(4):211–8.

    Article  PubMed  Google Scholar 

  12. Schnipper JL, Kirwin JL, Cotugno MC, Wahlstrom SA, Brown BA, Tarvin E, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006;166(5):565–71.

    Article  PubMed  Google Scholar 

  13. Ni W, Colayco D, Hashimoto J, Komoto K, Gowda C, Wearda B, et al. Reduction of healthcare costs through a transitions-of-care program. Am J Health Syst Pharm. 2018;75(10):613–21.

    Article  PubMed  Google Scholar 

  14. Ensing HT, Stuijt CC, van den Bemt BJ, van Dooren AA, Karapinar-Çarkit F, Koster ES, et al. Identifying the optimal role for pharmacists in care transitions: a systematic review. J Manag Care Spec Pharm. 2015;21(8):614–36.

    PubMed  Google Scholar 

  15. Canadian Pharmacists Association. Blueprint for Pharmacy-Implementation Plan. Available: https://www.pharmacists.ca/cpha-ca/assets/File/pharmacy-in-canada/blueprint/Blueprint%20Implementation%20Plan_FINAL%20-%20March%202010.pdf. Accessed 4 January 2020.

  16. Houle SK, Grindrod KA, Chatterley T, Tsuyuki RT. Paying pharmacists for patient care: a systematic review of remunerated pharmacy clinical care services. Can Pharm J (Ott). 2014;147(4):209–32.

    Article  PubMed Central  Google Scholar 

  17. Xu G. Analysis of pharmacy service fee in community pharmacies under the background of separation of medicine and pharmacy. Chin Pharm Affairs. 2018;32(11):1462–6.

    Google Scholar 

  18. The Consensus Chinese Pharmacy Service Standards and Charges of Experts. Drug Eval. (Chinese). 2016;13(14):8–15.

Download references

Acknowledgements

None.

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Shusen Sun or Jian Xiao.

Ethics declarations

Conflicts of interest

All authors declare that they have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, L., Huang, Y., Huang, X. et al. Ambulatory care pharmacy practice in China: status and future efforts. Int J Clin Pharm 42, 321–325 (2020). https://doi.org/10.1007/s11096-020-00998-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-020-00998-2

Keywords

Navigation